These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16647885)

  • 1. Prediction of arrhythmic events with positron emission tomography: PAREPET study design and methods.
    Fallavollita JA; Luisi AJ; Michalek SM; Valverde AM; deKemp RA; Haka MS; Hutson AD; Canty JM
    Contemp Clin Trials; 2006 Aug; 27(4):374-88. PubMed ID: 16647885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy.
    Fallavollita JA; Heavey BM; Luisi AJ; Michalek SM; Baldwa S; Mashtare TL; Hutson AD; Dekemp RA; Haka MS; Sajjad M; Cimato TR; Curtis AB; Cain ME; Canty JM
    J Am Coll Cardiol; 2014 Jan; 63(2):141-9. PubMed ID: 24076296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Denervated Myocardium Is Preferentially Associated With Sudden Cardiac Arrest in Ischemic Cardiomyopathy: A Pilot Competing Risks Analysis of Cause-Specific Mortality.
    Fallavollita JA; Dare JD; Carter RL; Baldwa S; Canty JM
    Circ Cardiovasc Imaging; 2017 Aug; 10(8):. PubMed ID: 28794139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of denervated myocardium on improving risk stratification for sudden cardiac death.
    Cain ME
    Trans Am Clin Climatol Assoc; 2014; 125():141-53; discussion 153. PubMed ID: 25125727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron Emission Tomography Imaging of Regional Versus Global Myocardial Sympathetic Activity to Improve Risk Stratification in Patients With Ischemic Cardiomyopathy.
    Zelt JGE; Wang JZ; Mielniczuk LM; Beanlands RSB; Fallavollita JA; Canty JM; deKemp RA
    Circ Cardiovasc Imaging; 2021 Jun; 14(6):e012549. PubMed ID: 34102857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional 11C-hydroxyephedrine retention in hibernating myocardium: chronic inhomogeneity of sympathetic innervation in the absence of infarction.
    Luisi AJ; Suzuki G; Dekemp R; Haka MS; Toorongian SA; Canty JM; Fallavollita JA
    J Nucl Med; 2005 Aug; 46(8):1368-74. PubMed ID: 16085596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance of Imaging Myocardial Sympathetic Innervation.
    Malhotra S; Fernandez SF; Fallavollita JA; Canty JM
    Curr Cardiol Rep; 2015 Aug; 17(8):62. PubMed ID: 26087899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of CMR and PET in Predicting Ventricular Arrhythmias in Ischemic Cardiomyopathy Patients Eligible for ICD.
    Rijnierse MT; van der Lingen ACJ; de Haan S; Becker MAJ; Harms HJ; Huisman MC; Lammertsma AA; van de Ven PM; van Rossum AC; Knaapen P; Allaart CP
    JACC Cardiovasc Imaging; 2020 Aug; 13(8):1755-1766. PubMed ID: 32305468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Approaches in the Management of Sudden Cardiac Death in Patients with Heart Failure-Targeting the Sympathetic Nervous System.
    Kiuchi MG; Nolde JM; Villacorta H; Carnagarin R; Chan JJS; Lugo-Gavidia LM; Ho JK; Matthews VB; Dwivedi G; Schlaich MP
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
    Vester EG; Dees H; Dobran I; Hennersdorf M; Perings C; Heydthausen M; Winter J; Strauer BE
    Z Kardiol; 2000; 89 Suppl 3():194-205. PubMed ID: 10810803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging for sudden cardiac death risk stratification: Current perspective and future directions.
    van der Bijl P; Delgado V; Bax JJ
    Prog Cardiovasc Dis; 2019; 62(3):205-211. PubMed ID: 31054859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Will imaging assist in the selection of patients with heart failure for an ICD?
    Gerson MC; Abdallah M; Muth JN; Costea AI
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):101-10. PubMed ID: 20129539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of viability, ischemia, scar tissue, and revascularization on outcome after aborted sudden death.
    van der Burg AE; Bax JJ; Boersma E; Pauwels EK; van der Wall EE; Schalij MJ
    Circulation; 2003 Oct; 108(16):1954-9. PubMed ID: 14530201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympathetic denervation is associated with microvascular dysfunction in non-infarcted myocardium in patients with cardiomyopathy.
    Rijnierse MT; Allaart CP; de Haan S; Harms HJ; Huisman MC; Wu L; Beek AM; Lammertsma AA; van Rossum AC; Knaapen P
    Eur Heart J Cardiovasc Imaging; 2015 Jul; 16(7):788-98. PubMed ID: 25711350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial scar and insulin resistance predict cardiovascular events in severe ischaemic myocardial dysfunction: a perfusion-metabolism positron emission tomography study.
    Feola M; Biggi A; Chauvie S; Vado A; Leonardi G; Rolfo F; Ribichini F
    Nucl Med Commun; 2008 May; 29(5):448-54. PubMed ID: 18391729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
    Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
    Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino-terminal pro-brain natriuretic peptide predicts ventricular arrhythmogenesis in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillators.
    Manios EG; Kallergis EM; Kanoupakis EM; Mavrakis HE; Kambouraki DC; Arfanakis DA; Vardas PE
    Chest; 2005 Oct; 128(4):2604-10. PubMed ID: 16236931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction.
    Williams MJ; Odabashian J; Lauer MS; Thomas JD; Marwick TH
    J Am Coll Cardiol; 1996 Jan; 27(1):132-9. PubMed ID: 8522686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.